Streetbeat News

Analyst Ratings

TENB

Wedbush analyst Daniel Ives maintains an Outperform rating on Tenable Holdings (NASDAQ:TENB) and raises the price target from $50 to $65.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:44 pm

EW

Mizuho analyst Anthony Petrone has maintained a Buy rating on Edwards Lifesciences (NYSE:EW) and increased the price target from $85 to $95.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:43 pm

DD

Mizuho analyst John Roberts maintains a Buy rating on DuPont de Nemours (NYSE:DD) but lowers the price target from $80 to $76 as of 6th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:42 pm

CHKP

Wedbush analyst Daniel Ives maintains an Outperform rating on Check Point Software (CHKP) and raises the price target from $170 to $185.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:40 pm

CRNC

Wedbush analyst Daniel Ives maintains a Neutral rating on Cerence (NASDAQ:CRNC) and raises the price target from $19 to $21.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:39 pm

CHKP

Mizuho analyst Gregg Moskowitz maintains a Neutral rating on Check Point Software (CHKP) and raises the price target from $150 to $160 as of 6th February 2024.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:38 pm

HRB

Goldman Sachs analyst George Kelly has maintained a Sell rating on H&R Block (NYSE:HRB) but raised the price target from $34 to $38.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:30 pm

AMGN

Goldman Sachs analyst Salveen Richter maintains a Buy rating on Amgen (NASDAQ:AMGN) and raises the price target from $313 to $350.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:29 pm

VFC

Wedbush analyst Tom Nikic maintains a Neutral rating on VF Corporation (VFC) and lowers the price target from $16.5 to $15.5.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:26 pm

RLYB

Wedbush analyst Laura Chico maintains an Outperform rating on Rallybio (NASDAQ:RLYB) but lowers the price target from $14 to $13.

Portfolio Pulse from Benzinga Newsdesk

February 07, 2024 | 1:23 pm